UNSPSC 51283934: Sulfatrozole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C10H12N4O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G91KDP4M35, chemically known as n1-(4-ethoxy-1,2,5-thiadiazol-3-yl)sulfanilamid but generally known as sulfatrozole, which bears US NIH Compound Identifier 216260. European Medicines Agency schedules Sulfatrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10735MIG.

UNSPSC 51283934 Sulfatrozole, a Commodity code, nominally covers a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code show no procurement activity for sulfatrozole itself. Instead, the opportunities reflect a broader pattern of state and local health agencies, counties, and special-purpose purchasing alliances acquiring naloxone, generic multi-source pharmaceuticals, over-the-counter products, and related emergency medical supplies through competitive bidding and cooperative purchasing frameworks. The actual buying under this code spans pharmaceutical products, emergency response medications, and medical consumables sourced from manufacturers and distributed through authorized wholesalers and direct vendor channels. Issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP).

Recent activity concentrates in Florida and Minnesota, with Texas involved in exploratory market-intelligence gathering. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; City of Tampa's sealed-bid procurement 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000 with a five percent bid discount for certified Small Local Business Enterprises; and MMCAP's RFP S1070000015802 (due March 26, 2026) for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with pricing weighted at seventy-five percent and compliance with cGMP and Drug Supply Chain Security Act requirements. The code appears to serve as a catch-all taxonomy entry for pharmaceutical and medical-supply procurement rather than a precise match to the sulfatrozole commodity itself, creating potential misclassification risk in opportunity screening.